His son, Brennan, was diagnosed with T1D at age 4 after a revelation at a family reunion. Alan’s stepmother, a nurse, noticed that Brennan was exhibiting the symptoms of type 1 diabetes – including extreme thirst and excessive trips to the bathroom. In a recent interview, Thicke described how the first months after Brennan’s diagnosis were especially stressful and scary: “After hours of cajoling and chasing him around the house I had to pin him to the floor to give him his [insulin] shot. He was kicking and screaming.” When Thicke was reduced to tears, young Brennan came to a realization. “He recognized he wasn’t being punished by getting a shot, and that the shots were hurting me almost as much as they were hurting him… That changed our whole relationship. He realized we were a team.”
The Thickes’ difficulties managing T1D are all too familiar to millions of families worldwide. In recent years, research has led to improvements in treatment, including pumps and continuous glucose monitors that have offered people with T1D a better quality of life, but Thicke never lost sight of his crusade for a cure.
On behalf of everyone at JDRF and the entire T1D community, we extend our heartfelt condolences to Thicke’s family, friends and colleagues, and we thank Thicke for his endless support of type 1 diabetes awareness and research. Because of his efforts and those of his family beginning decades ago, countless people are leading safer, happier lives today.
About Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone people need to get energy from food. T1D strikes both children and adults and has nothing to do with diet or lifestyle. There is currently nothing you can do to prevent it. People with T1D must regularly monitor their blood sugar level, inject or continually infuse insulin through a pump, and carefully balance their insulin doses with eating and daily activities throughout the day and night. However, insulin is not a cure for diabetes, and even with intensive disease management, a significant portion of the day is still spent with either high or low blood sugar levels, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, and amputation.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested nearly $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF.